Evaluation of the Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Long-Term Survival and Morbidity Profile: A Systematic Review of the Peritoneal Carcinomatosis Management. [PDF]
Sarmiento Bonilla CI +8 more
europepmc +1 more source
Effect of hyperthermic intraperitoneal chemotherapy on thrombin generation and fibrinolysis. [PDF]
Lundbech M +4 more
europepmc +1 more source
Expanding the role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study on uncommon peritoneal malignancies. [PDF]
Framarini M +6 more
europepmc +1 more source
The Effect of Induced Hypothermia on Postoperative Outcomes Following Hyperthermic Intraperitoneal Chemotherapy: A Negative Finding. [PDF]
Yang MC +5 more
europepmc +1 more source
Endostar combined with docetaxel or cisplatin in the management of malignant ascites through hyperthermic intraperitoneal chemotherapy: A retrospective cohort study. [PDF]
Wu J +5 more
europepmc +1 more source
Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases-Should It Be Offered? [PDF]
Foster JM, Nash GM, Möller MG.
europepmc +1 more source
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS + HIPEC): an initial experience at a Tertiary care Hospital in Pakistan. [PDF]
Aimon S, Khan HM, Khan U, Atiq M.
europepmc +1 more source
Hyperthermic intraperitoneal chemotherapy with raltitrexed for peritoneal recurrence presenting with massive ascites following radical surgery for advanced gastric cancer: a case report. [PDF]
Xie W, Deng L, Mou R, Liu K.
europepmc +1 more source

